Visco Vision Inc. (TPE:6782)
168.50
-0.50 (-0.30%)
Aug 1, 2025, 1:30 PM CST
Blueprint Medicines Revenue
Visco Vision had revenue of 947.12M TWD in the quarter ending March 31, 2025, with 16.08% growth. This brings the company's revenue in the last twelve months to 3.80B, up 41.48% year-over-year. In the year 2024, Visco Vision had annual revenue of 3.67B with 53.13% growth.
Revenue (ttm)
3.80B
Revenue Growth
+41.48%
P/S Ratio
2.79
Revenue / Employee
n/a
Employees
n/a
Market Cap
10.62B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.67B | 1.27B | 53.13% |
Dec 31, 2023 | 2.40B | -379.85M | -13.68% |
Dec 31, 2022 | 2.78B | 813.03M | 41.39% |
Dec 31, 2021 | 1.96B | 438.11M | 28.70% |
Dec 31, 2020 | 1.53B | 54.37M | 3.69% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Caliway Biopharmaceuticals | 40.47M |
PharmaEssentia | 11.34B |
Bora Pharmaceuticals Co., LTD. | 20.87B |
Lotus Pharmaceutical | 19.12B |
Oneness Biotech | 117.33M |
Polaris Group | 87.67M |
Center Laboratories | 1.63B |
Pegavision | 6.67B |